Silencing PKM2 inhibits HCC proliferation, migration, and invasion whereas overexpression of PKM2 increases interferon gamma (IFNγ)-positive CD8+ T cells in the HCC mouse model by activating an immune checkpoint blockade (94). The gene discussed is CD8A; the disease is hepatocellular carcinoma.